+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Biopharmaceuticals Market Research Reports

From
From
Allergy Vaccines Market - Global Strategic Business Report - Product Thumbnail Image

Allergy Vaccines Market - Global Strategic Business Report

  • Report
  • May 2026
  • 481 Pages
  • Global
From
From
From
From
From
From
From
Rubella Vaccines Market - Global Strategic Business Report - Product Thumbnail Image

Rubella Vaccines Market - Global Strategic Business Report

  • Report
  • May 2026
  • 275 Pages
  • Global
From
From
Subunit Vaccines Market - Global Strategic Business Report - Product Thumbnail Image

Subunit Vaccines Market - Global Strategic Business Report

  • Report
  • May 2026
  • 279 Pages
  • Global
From
Toxoid Vaccines Market - Global Strategic Business Report - Product Thumbnail Image

Toxoid Vaccines Market - Global Strategic Business Report

  • Report
  • May 2026
  • 282 Pages
  • Global
From
From
From
From
Mumps Vaccines Market - Global Strategic Business Report - Product Thumbnail Image

Mumps Vaccines Market - Global Strategic Business Report

  • Report
  • May 2026
  • 288 Pages
  • Global
From
Nasal Vaccines Market - Global Strategic Business Report - Product Thumbnail Image

Nasal Vaccines Market - Global Strategic Business Report

  • Report
  • May 2026
  • 220 Pages
  • Global
From
From
Adult Vaccines Market - Global Strategic Business Report - Product Thumbnail Image

Adult Vaccines Market - Global Strategic Business Report

  • Report
  • May 2026
  • 377 Pages
  • Global
From
Loading Indicator

The biopharmaceuticals market is a sector of the pharmaceutical industry that focuses on the development and production of drugs derived from biological sources. These drugs are typically produced using recombinant DNA technology, which involves the manipulation of genetic material to create proteins and other molecules with therapeutic properties. Biopharmaceuticals are used to treat a wide range of diseases, including cancer, HIV/AIDS, and autoimmune disorders. Biopharmaceuticals are typically more expensive to produce than traditional pharmaceuticals, but they offer a number of advantages, such as improved efficacy and fewer side effects. They are also more targeted, meaning they can be used to treat specific conditions more effectively. Some of the major companies in the biopharmaceuticals market include Amgen, Biogen, Celgene, Gilead Sciences, and Novartis. These companies are involved in the development and production of a wide range of biopharmaceuticals, including monoclonal antibodies, vaccines, and gene therapies. Show Less Read more